Condition
Supraglottic Squamous Cell Carcinoma
Total Trials
4
Recruiting
1
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Active Not Recruiting2
Completed1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02984410Not ApplicableActive Not Recruiting
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT01819480Not ApplicableActive Not Recruiting
Efficacy and Safety of TORS for SCCA
NCT05611515RecruitingPrimary
Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies
NCT03357107CompletedPrimary
Local Control After Robot-assisted Supraglottic Laryngectomy
Showing all 4 trials